Ochre Bio
Oxford, United Kingdom · StartupBiotech company using AI and genomics to develop RNA therapies targeting chronic liver disease.
Global growth investor with teams in Europe scaling healthcare, fintech, and deep tech companies.
London, United Kingdom
Venture Capital
Series B+
/united-kingdom/venture-capital/eight-roads-ventures
No portfolio startups have been linked yet.
Biotech company using AI and genomics to develop RNA therapies targeting chronic liver disease.
11x is the breakout star of the UK's agentic AI wave, known for building "digital workers" that replace full job functions rather than merely assisting them. Founded in 2022 by Hasan Sukkar, the company frames its product as autonomous employees rather than software tools. That positioning is controversial, but it resonates with revenue teams seeking to eliminate manual drudgery and scale outreach without linear headcount growth. The flagship product, Alice, is an AI Sales Development Representative that can source leads, research accounts, craft highly personalized outreach, and follow up continuously. In late 2024, 11x launched Jordan, a multilingual AI phone agent that conducts real-time voice conversations for qualification and support in more than 30 languages. Together, these agents can run a large portion of the outbound funnel end-to-end, from initial outreach to handoff, with human oversight focused on high-value exceptions. By early 2026, 11x had exploded in valuation after a Series B led by Andreessen Horowitz, a rare win for a UK-first startup. The company processes millions of interactions for high-growth tech companies such as Otter.ai and Airwallex and is expanding its footprint in San Francisco to preempt US-based competitors. The roadmap centers on "digital teams" that coordinate multiple agents across tasks: one agent identifies a lead, another calls, a third negotiates logistics, and a final agent drafts the contract. This orchestration layer is the company's strategic bet on becoming the default system for revenue operations. The company's roots include Y Combinator's Summer 2023 batch, which accelerated its US network and credibility, and its UK engineering base sits in the London Bridge tech hub. Investor support spans US and European capital: a16z led the Series B, Benchmark led the Series A, Lux Capital participated early, Quiet Capital backed growth, and 20VC provided influential local support. In 2026, 11x is the UK's most visible play on AI-native revenue teams, aiming to become a category-defining platform for autonomous sales operations.
AdMagica is a generative AI platform for e-commerce ad creative production, with corporate presence in London and core operations in Tbilisi. The product helps performance marketing teams generate, resize, and test conversion-oriented creatives faster across social channels, reducing creative fatigue and production overhead. The company emerged from the 500 Eurasia Batch 9 ecosystem and targets European commerce brands.
Europe's largest cell and gene therapy event. Price: about GBP 2000; startups often access subsidized exhibition pods. Strong for biotech founders and manufacturing partners.
Agoranov is a Paris-based public incubator founded in 2000 by a consortium of universities and research institutions. It supports science- and technology-intensive startups, often spun out of academic labs, and has backed 400+ startups that raised €1.5B+ and created 10,000+ jobs. Program: office space in central Paris, a 6-month renewable incubation program with tailored mentorship, research access, grant support, and investor introductions. As a public-interest incubator, Agoranov is equity-free and funded by French public institutions and the City of Paris. Unicorn alumni: - Doctolib - Alan - Criteo
Conference and expo covering enterprise AI, data platforms, and applied machine learning.
Checking login status...
Loading comments...